These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18161485)

  • 1. Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies.
    Ma S; Gundlach AL
    Adv Exp Med Biol; 2007; 612():119-37. PubMed ID: 18161485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic targeting of relaxin and insl3 signaling in mice.
    Feng S; Bogatcheva NV; Kamat AA; Agoulnik AI
    Ann N Y Acad Sci; 2005 May; 1041():82-90. PubMed ID: 15956690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coevolution of the relaxin-like peptides and their receptors.
    Wilkinson TN; Speed TP; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():534-9. PubMed ID: 15956757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin, the relaxin-like factor and their receptors.
    Schwabe C; Büllesbach EE
    Adv Exp Med Biol; 2007; 612():14-25. PubMed ID: 18161478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
    Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW
    Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of the relaxin peptide family and their receptors.
    Wilkinson TN; Bathgate RA
    Adv Exp Med Biol; 2007; 612():1-13. PubMed ID: 18161477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
    Kuei C; Sutton S; Bonaventure P; Pudiak C; Shelton J; Zhu J; Nepomuceno D; Wu J; Chen J; Kamme F; Seierstad M; Hack MD; Bathgate RA; Hossain MA; Wade JD; Atack J; Lovenberg TW; Liu C
    J Biol Chem; 2007 Aug; 282(35):25425-35. PubMed ID: 17606621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
    Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
    Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin family peptides and their receptors.
    Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
    Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
    Sutton SW; Bonaventure P; Kuei C; Nepomuceno D; Wu J; Zhu J; Lovenberg TW; Liu C
    Neuroendocrinology; 2005; 82(3-4):139-50. PubMed ID: 16679775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the mouse and rat relaxin receptors.
    Scott DJ; Layfield S; Riesewijk A; Morita H; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():8-12. PubMed ID: 15956680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative localization of leucine-rich repeat-containing G-protein-coupled receptor-7 (RXFP1) mRNA and [33P]-relaxin binding sites in rat brain: restricted somatic co-expression a clue to relaxin action?
    Ma S; Shen PJ; Burazin TC; Tregear GW; Gundlach AL
    Neuroscience; 2006 Aug; 141(1):329-44. PubMed ID: 16725278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo.
    Bathgate RA; Lin F; Hanson NF; Otvos L; Guidolin A; Giannakis C; Bastiras S; Layfield SL; Ferraro T; Ma S; Zhao C; Gundlach AL; Samuel CS; Tregear GW; Wade JD
    Biochemistry; 2006 Jan; 45(3):1043-53. PubMed ID: 16411781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane receptors: structure and function of the relaxin family peptide receptors.
    Kong RC; Shilling PJ; Lobb DK; Gooley PR; Bathgate RA
    Mol Cell Endocrinol; 2010 May; 320(1-2):1-15. PubMed ID: 20138959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-relaxin family peptide signaling and receptors in mouse brain membranes and neuronal cells.
    Ortinau S; Lin F; Wade JD; Tregear GW; Bathgate RA; Gundlach AL
    Ann N Y Acad Sci; 2005 May; 1041():211-5. PubMed ID: 15956710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
    Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in relaxin-3-related research.
    Liu C; Bonaventure P; Sutton SW; Chen J; Kuei C; Nepomuceno D; Lovenberg TW
    Ann N Y Acad Sci; 2005 May; 1041():47-60. PubMed ID: 15956687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of the signaling system in relaxin-family peptides.
    Hsu SY; Semyonov J; Park JI; Chang CL
    Ann N Y Acad Sci; 2005 May; 1041():520-9. PubMed ID: 15956755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxin family peptide systems and the central nervous system.
    Callander GE; Bathgate RA
    Cell Mol Life Sci; 2010 Jul; 67(14):2327-41. PubMed ID: 20213277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.